EGFR and neoplasm: Similar to the results of cell proliferation study, the inhibitory effect of SH-1028 on EGFR phosphorylation in PC-9 cells was stronger than that of osimertinib, while the inhibitory effects of Imp3 on EGFR phosphorylation in tumor cell lines were relatively similar to those of osimertinib at various time points.